In CKD, galectin-3 serves as a prognostic biomarker linked to increased all-cause mortality and kidney disease progression, with urinary galectin-3 levels correlating with renal fibrosis and decline in eGFR (132, 137). The gene discussed is LGALS3; the disease is renal fibrosis.